Xiu P - Search Results

1

Secretory clusterin contributes to oxaliplatin resistance by activating Akt pathway in hepatocellular carcinoma.

Xiu P, Dong X, Dong X, Xu Z, Zhu H, Liu F, Wei Z, Zhai B, Kanwar JR, Jiang H, Li J, Sun X. Xiu P, et al. Cancer Sci. 2013 Mar;104(3):375-82. doi: 10.1111/cas.12088. Epub 2013 Jan 30. Cancer Sci. 2013. PMID: 23279642 Free PMC article.

2

Downregulating sCLU enhances the sensitivity of hepatocellular carcinoma cells to gemcitabine by activating the intrinsic apoptosis pathway.

Xiu P, Xu Z, Liu F, Li Z, Li T, Zou F, Sun X, Li J. Xiu P, et al. Dig Dis Sci. 2014 Aug;59(8):1798-809. doi: 10.1007/s10620-014-3111-9. Epub 2014 Mar 27. Dig Dis Sci. 2014. PMID: 24671452

3

Meloxicam executes its antitumor effects against hepatocellular carcinoma in COX-2- dependent and -independent pathways.

Dong X, Li R, Xiu P, Dong X, Xu Z, Zhai B, Liu F, Jiang H, Sun X, Li J, Qiao H. Dong X, et al. Among authors: xiu p. PLoS One. 2014 Mar 27;9(3):e92864. doi: 10.1371/journal.pone.0092864. eCollection 2014. PLoS One. 2014. PMID: 24675684 Free PMC article.

4

Integrin αvβ3 is required for cathepsin B-induced hepatocellular carcinoma progression.

Xu ZZ, Xiu P, Lv JW, Wang FH, Dong XF, Liu F, Li T, Li J. Xu ZZ, et al. Among authors: xiu p. Mol Med Rep. 2015 May;11(5):3499-504. doi: 10.3892/mmr.2014.3140. Epub 2014 Dec 30. Mol Med Rep. 2015. PMID: 25572981

5

Clusterin: Review of research progress and looking ahead to direction in hepatocellular carcinoma.

Xiu P, Dong XF, Li XP, Li J. Xiu P, et al. World J Gastroenterol. 2015 Jul 21;21(27):8262-70. doi: 10.3748/wjg.v21.i27.8262. World J Gastroenterol. 2015. PMID: 26217078 Free PMC article. Review.

6

Meloxicam combined with sorafenib synergistically inhibits tumor growth of human hepatocellular carcinoma cells via ER stress-related apoptosis.

Zhong J, Xiu P, Dong X, Wang F, Wei H, Wang X, Xu Z, Liu F, Li T, Wang Y, Li J. Zhong J, et al. Among authors: xiu p. Oncol Rep. 2015 Oct;34(4):2142-50. doi: 10.3892/or.2015.4181. Epub 2015 Aug 6. Oncol Rep. 2015. PMID: 26252057

7

Meloxicam suppresses hepatocellular carcinoma cell proliferation and migration by targeting COX-2/PGE2-regulated activation of the β-catenin signaling pathway.

Li T, Zhong J, Dong X, Xiu P, Wang F, Wei H, Wang X, Xu Z, Liu F, Sun X, Li J. Li T, et al. Among authors: xiu p. Oncol Rep. 2016 Jun;35(6):3614-22. doi: 10.3892/or.2016.4764. Epub 2016 Apr 20. Oncol Rep. 2016. PMID: 27109804

8

Verteporfin suppresses cell survival, angiogenesis and vasculogenic mimicry of pancreatic ductal adenocarcinoma via disrupting the YAP-TEAD complex.

Wei H, Wang F, Wang Y, Li T, Xiu P, Zhong J, Sun X, Li J. Wei H, et al. Among authors: xiu p. Cancer Sci. 2017 Mar;108(3):478-487. doi: 10.1111/cas.13138. Cancer Sci. 2017. PMID: 28002618 Free PMC article.

9

Secretory Clusterin Mediates Oxaliplatin Resistance via the Gadd45a/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma.

Wang X, Zou F, Zhong J, Yue L, Wang F, Wei H, Yang G, Jin T, Dong X, Li J, Xiu P. Wang X, et al. Among authors: xiu p. J Cancer. 2018 Apr 6;9(8):1403-1413. doi: 10.7150/jca.23849. eCollection 2018. J Cancer. 2018. PMID: 29721050 Free PMC article.

10

T7 peptide inhibits angiogenesis via downregulation of angiopoietin-2 and autophagy.

Wang F, Dong X, Xiu P, Zhong J, Wei H, Xu Z, Li T, Liu F, Sun X, Li J. Wang F, et al. Among authors: xiu p. Oncol Rep. 2015 Feb;33(2):675-84. doi: 10.3892/or.2014.3653. Epub 2014 Dec 5. Oncol Rep. 2015. PMID: 25483829

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters